Discordance Among Transient Elastography, Aspartate Aminotransferase to Platelet Ratio Index, and Histologic Assessments of Liver Fibrosis in Patients With Chronic Hepatitis C

被引:23
|
作者
Gara, Naveen [1 ]
Zhao, Xiongce [2 ]
Kleiner, David E. [3 ]
Liang, T. Jake [1 ]
Hoofnagle, Jay H. [1 ]
Ghany, Marc G. [1 ]
机构
[1] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA
[2] NIDDK, NIH, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
HCV; Liver Disease; Cancer Risk; AUROC; SIGNIFICANT PORTAL-HYPERTENSION; STIFFNESS MEASUREMENT; HEPATOCELLULAR-CARCINOMA; RISK-ASSESSMENT; XL PROBE; BIOPSY; DIAGNOSIS; CIRRHOSIS; FEASIBILITY; PERFORMANCE;
D O I
10.1016/j.cgh.2012.10.044
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Liver biopsy is the standard for assessing hepatic fibrosis. Ultrasound transient elastography (TE) and the aspartate aminotransferase to platelet ratio index (APRI) are validated, noninvasive tests for identifying patients with cirrhosis. We evaluated discordance among TE, APRI, and histology diagnoses of cirrhosis. METHODS: We analyzed findings from 109 patients with chronic hepatitis C who underwent TE within 6 months of liver biopsy at the US National Institutes of Health from 2006 to 2011. Fibrosis was scored using the Ishak scale (0-6). APRI scores were calculated using data collected on the day of the biopsy. Area under receiver operator characteristic curves for TE and APRI were calculated to distinguish patients with cirrhosis (Ishak scores, 5-6) from those without cirrhosis (Ishak scores, 0-4). The best cut-off value and corresponding positive predictive value (PPV) and negative predictive value (NPV) were selected. RESULTS: Based on biopsy analysis, 18% of the patients had no fibrosis, 52% had mild fibrosis, 17% had bridging fibrosis, and 13% had cirrhosis. A TE cut-off value of 13.1 kPa identified patients with cirrhosis with the highest level of accuracy (100% sensitivity, 89% specificity, 58% PPV, 100% NPV), as did an APRI cut-off value of 1.0 (79% sensitivity, 78% specificity, 34% PPV, 96% NPV). Results from TE and APRI were discordant for 28% of cases. TE identified all cases of cirrhosis and an additional 10 patients who were not found to have cirrhosis based on histology analysis; 7 of these patients had clinical or radiologic evidence of cirrhosis, indicating that the biopsy sample was not staged correctly. CONCLUSIONS: TE increases the accuracies of biopsy and APRI analyses in identifying patients with cirrhosis. TE also might be used to screen patients for cirrhosis and identify those who should be followed up for development of hepatocellular carcinoma and varices.
引用
收藏
页码:303 / +
页数:7
相关论文
共 50 条
  • [1] Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients
    Sripongpun, Pimsiri
    Tangkijvanich, Pisit
    Chotiyaputta, Watcharasak
    Charatcharoenwitthaya, Phunchai
    Chaiteerakij, Roongruedee
    Treeprasertsuk, Sombat
    Bunchorntavakul, Chalermrat
    Sobhonslidsuk, Abhasnee
    Leerapun, Apinya
    Khemnark, Suparat
    Poovorawan, Kittiyod
    Siramolpiwat, Sith
    Chirapongsathorn, Sakkarin
    Pan-Ngum, Wirichada
    Soonthornworasiri, Ngamphol
    Sukeepaisarnjaroen, Wattana
    [J]. JGH OPEN, 2020, 4 (01): : 69 - 74
  • [2] Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis
    Sirli, Roxana
    Sporea, Ioan
    [J]. HEPATITIS MONTHLY, 2011, 11 (07) : 560 - 561
  • [3] Aspartate aminotransferase-to-platelet ratio index for fibrosis and cirrhosis prediction in chronic hepatitis C patients
    da Silva Junior, Roberto Gomes
    Fakhouri, Ricardo
    Bezerra do Nascimento, Tereza Virginia
    Santos, Igor Martins
    Morais Barbosa, Luciana Mendonca
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (01): : 15 - 19
  • [4] Aspartate aminotransferase to platelet ratio index for the evaluation of fibrosis in chronic viral hepatitis
    Yetkin, M. A.
    Bulut, C.
    Caydere, M.
    Erdinc, F. S.
    Ertem, G.
    Kinikli, S.
    Tuelek, N.
    Uestuen, H.
    Demiroz, A. P.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S538 - S538
  • [5] Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis
    Lieber, CS
    Weiss, DG
    Morgan, TR
    Paronetto, F
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (07): : 1500 - 1508
  • [6] Aspartate aminotransferase to platelet ratio index for the evaluation of fibrosis in chronic viral hepatitis
    Aghasadeghi, M.
    Sadat, M.
    Khabiri, A.
    Rouhvand, F.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S538 - S538
  • [7] Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis
    Chrysanthos, Nikolaos V.
    Papatheodoridis, George V.
    Savvas, Savvas
    Kafiri, Georgia
    Petraki, Kalliopi
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (04) : 389 - 396
  • [8] Transient Elastography vs. Aspartate Aminotransferase to Platelet Ratio Index in Hepatitis C: A Meta-Analysis
    de Mattos, Angelo Zambam
    de Mattos, Angelo Alves
    [J]. ANNALS OF HEPATOLOGY, 2017, 16 (03) : 349 - 357
  • [9] Accuracy of the aspartate aminotransferase to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis in chronic hepatitis C and B
    Zulkhairi, Zulkhairi
    Adlin, Herry
    Elias, Tarigan
    Lukman, Hakim Zain
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 212 - 212
  • [10] Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B
    Shin, W. G.
    Park, S. H.
    Jang, M. K.
    Hahn, T. H.
    Kim, J. B.
    Lee, M. S.
    Kim, D. J.
    Jun, S. -Y
    Park, C. K.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 (04) : 267 - 274